[Heart failure due to dilated cardiomyopathy].
Hiramitsu
Shinya
S
Division of Cardiology, Department of Internal Medicine, Fujita Health University, School of Medicine.
Miyagishima
Kenji
K
Mori
Kazumasa
K
Kimura
Hisashi
H
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial / Q000379:methods; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors